News Extra [these Stories Appear Only On The Web]

AMA promotes benefits of “genetically improved” foods

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7317.828/f (Published 13 October 2001) Cite this as: BMJ 2001;323:828
  1. Janice Hopkins
  1. New

    Although biotechnology has produced greatly improved, widely accepted drugs, there is still enormous controversy over the development of genetically modified crops that increase yields, lower costs, and offer better ways to feed the world, the director of science policy at the American Medical Association has said.

    Speaking at a New York press briefing last week, Dr Barry David Dickinson, director of science policy for the American Medical Association, said that biotechnological advances had improved human insulin, growth hormone, monoclonal antibodies, tissue plasminogen activator (TPA), and more.

    “Why, then, is there controversy over genetically modified crops?” he asked.

    The seminar was funded by an unrestricted grant from the Council for Biotechnology Information, a group of six biotechnology firms and two trade associations. They included Aventis …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe